SG11202007222RA - Antibody purification - Google Patents

Antibody purification

Info

Publication number
SG11202007222RA
SG11202007222RA SG11202007222RA SG11202007222RA SG11202007222RA SG 11202007222R A SG11202007222R A SG 11202007222RA SG 11202007222R A SG11202007222R A SG 11202007222RA SG 11202007222R A SG11202007222R A SG 11202007222RA SG 11202007222R A SG11202007222R A SG 11202007222RA
Authority
SG
Singapore
Prior art keywords
antibody purification
antibody
purification
Prior art date
Application number
SG11202007222RA
Other languages
English (en)
Inventor
Timothy Iskra
Ashley Margaret Sacramo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG11202007222RA publication Critical patent/SG11202007222RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11202007222RA 2018-02-27 2019-02-25 Antibody purification SG11202007222RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862635943P 2018-02-27 2018-02-27
PCT/IB2019/051498 WO2019166932A1 (fr) 2018-02-27 2019-02-25 Purification d'anticorps

Publications (1)

Publication Number Publication Date
SG11202007222RA true SG11202007222RA (en) 2020-09-29

Family

ID=66049355

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202007222RA SG11202007222RA (en) 2018-02-27 2019-02-25 Antibody purification

Country Status (11)

Country Link
US (1) US20210017254A1 (fr)
EP (1) EP3759134A1 (fr)
JP (2) JP7449041B2 (fr)
CN (1) CN111788222A (fr)
AU (2) AU2019228377B2 (fr)
BR (1) BR112020015603A2 (fr)
CA (1) CA3034795A1 (fr)
IL (1) IL276816A (fr)
MX (1) MX2020008931A (fr)
SG (1) SG11202007222RA (fr)
WO (1) WO2019166932A1 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4205938A1 (de) * 1992-02-27 1993-09-02 Medac Klinische Spezialpraep Immunotoxine
BRPI0415887B1 (pt) * 2003-10-27 2021-01-26 Wyeth métodos para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
US20100234577A1 (en) * 2006-06-14 2010-09-16 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
WO2011143545A1 (fr) 2010-05-14 2011-11-17 Rinat Neuroscience Corporation Protéines hétérodimériques et leurs procédés de production et de purification
EP2635310A2 (fr) 2010-11-05 2013-09-11 Rinat Neuroscience Corp. Conjugués de polypeptides obtenus par génie biologique, et procédé de fabrication correspondants au moyen de transglutaminase
CN105473612A (zh) * 2013-08-19 2016-04-06 豪夫迈·罗氏有限公司 用羟基磷灰石层析分离双特异性抗体和双特异性抗体生产副产物
JP2018511300A (ja) * 2015-01-16 2018-04-26 アルダー・バイオファーマシューティカルズ・インコーポレーテッド 抗糖タンパク質抗体及びその使用
KR102405104B1 (ko) 2015-04-13 2022-06-07 화이자 인코포레이티드 치료 항체 및 그의 용도
TWI829617B (zh) * 2015-07-31 2024-01-21 德商安美基研究（慕尼黑）公司 Ｆｌｔ３及ｃｄ３抗體構築體
KR20180048731A (ko) * 2015-08-20 2018-05-10 제넨테크, 인크. 재조합 폴리펩티드를 제조하기 위한 fkpa의 정제 및 그의 용도
EP3630841A1 (fr) 2017-06-02 2020-04-08 Pfizer Inc. Anticorps spécifiques à la flt3 et leurs utilisations

Also Published As

Publication number Publication date
JP2019147793A (ja) 2019-09-05
MX2020008931A (es) 2020-10-01
CN111788222A (zh) 2020-10-16
BR112020015603A2 (pt) 2021-01-05
WO2019166932A1 (fr) 2019-09-06
CA3034795A1 (fr) 2019-08-27
TW201936644A (zh) 2019-09-16
AU2019228377B2 (en) 2023-02-23
KR20200115569A (ko) 2020-10-07
RU2020128326A3 (fr) 2022-03-28
JP2024042088A (ja) 2024-03-27
EP3759134A1 (fr) 2021-01-06
AU2023203205A1 (en) 2023-06-15
IL276816A (en) 2020-10-29
AU2019228377A1 (en) 2020-08-20
RU2020128326A (ru) 2022-03-28
JP7449041B2 (ja) 2024-03-13
US20210017254A1 (en) 2021-01-21

Similar Documents

Publication Publication Date Title
IL279321A (en) Anti-SIRPalpha antibody
SG11202106214YA (en) Novel anti-ccr8 antibody
IL280780A (en) Anti-TIGIT antibodies
IL279352A (en) IL-11RA antibodies
IL280013A (en) Anti-IL36R antibodies
IL278010A (en) Antibodies to galectin 10
IL277030A (en) Antibodies
GB202110263D0 (en) Anti-btla antibodies
ZA202101177B (en) Anti-btla antibody
GB201811368D0 (en) Antibody
IL280140A (en) Antigen purification method
IL281594A (en) Antibodies against KLRG1
ZA202108836B (en) Anti-epha4 antibody
GB201817172D0 (en) Antibody
GB201905150D0 (en) Ant-ige antibodies
GB201806084D0 (en) Antibodies
GB201917480D0 (en) Antibodies
GB201900732D0 (en) Antibodies
IL276816A (en) Antibody purification
SG11202105718TA (en) Modified antibodies
GB201919062D0 (en) Antibody
GB201813597D0 (en) Antibody
GB201912008D0 (en) Antibody
GB201819952D0 (en) Antibodies
GB201809945D0 (en) Antibody